Nejo Takahide, Krishna Saritha, Yamamichi Akane, Lakshmanachetty Senthilnath, Jimenez Christian, Lee Kevin Y, Baker Donovan L, Young Jacob S, Chen Tiffany, Phyu Su Su Sabai, Phung Lan, Gallus Marco, Maldonado Gabriella C, Okada Kaori, Ogino Hirokazu, Watchmaker Payal B, Diebold David, Choudhury Abrar, Daniel Andy G S, Cadwell Cathryn R, Raleigh David R, Hervey-Jumper Shawn L, Okada Hideho
Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA.
Department of Neurosurgery, University Hospital Muenster, Muenster, Germany.
Nat Commun. 2025 May 22;16(1):4770. doi: 10.1038/s41467-025-60074-z.
Neuronal activity-driven mechanisms influence glioblastoma cell proliferation and invasion, while glioblastoma remodels neuronal circuits. Although a subpopulation of malignant cells enhances neuronal connectivity, their impact on the immune system remains unclear. Here, we show that glioblastoma regions with enhanced neuronal connectivity exhibit regional immunosuppression, characterized by distinct immune cell compositions and the enrichment of anti-inflammatory tumor-associated macrophages (TAMs). In preclinical models, knockout of Thrombospondin-1 (TSP1/Thbs1) in glioblastoma cells suppresses synaptogenesis and glutamatergic neuronal hyperexcitability. Furthermore, TSP1 knockout restores antigen presentation-related genes, promotes the infiltration of pro-inflammatory TAMs and CD8 + T-cells in the tumor, and alleviates TAM-mediated T-cell suppression. Pharmacological inhibition of glutamatergic signaling also shifts TAMs toward a less immunosuppressive state, prolongs survival in mice, and shows the potential to enhance the efficacy of immune cell-based therapy. These findings confirm that glioma-neuronal circuit remodeling is strongly linked with regional immunosuppression and suggest that targeting glioma-neuron-immune crosstalk could provide avenues for immunotherapy.
神经元活动驱动机制影响胶质母细胞瘤细胞的增殖和侵袭,而胶质母细胞瘤会重塑神经回路。虽然恶性细胞的一个亚群增强了神经元连接性,但其对免疫系统的影响仍不清楚。在此,我们表明,具有增强神经元连接性的胶质母细胞瘤区域表现出局部免疫抑制,其特征为独特的免疫细胞组成以及抗炎性肿瘤相关巨噬细胞(TAM)的富集。在临床前模型中,胶质母细胞瘤细胞中血小板反应蛋白-1(TSP1/Thbs1)的敲除抑制了突触发生和谷氨酸能神经元的过度兴奋。此外,TSP1敲除可恢复抗原呈递相关基因,促进促炎性TAM和CD8 + T细胞在肿瘤中的浸润,并减轻TAM介导的T细胞抑制。谷氨酸能信号的药理学抑制也使TAM向免疫抑制性较低的状态转变,延长小鼠生存期,并显示出增强基于免疫细胞疗法疗效的潜力。这些发现证实胶质瘤-神经回路重塑与局部免疫抑制密切相关,并表明靶向胶质瘤-神经元-免疫串扰可为免疫治疗提供途径。